Evidence map›Paper›PMID 33915345›Full record

ArticleDiabetes & metabolic syndrome

Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery.

Mohammad Shafi Kuchay, Sunil Kumar Mishra, Yatin Mehta

Registry-linked trialAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Diabetes & metabolic syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT06187285. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06187285 nacompleted

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia: Randomised Control

Ran2024Enrolled220Registered outcomes10Posted comparisons0ConditionsType 2 DiabetesArmsempagliflozin 25 mg, Sitagliptin 100mg
PMID 22223765PMID 11588337PMID 11794168PMID 11889147PMID 12105309PMID 9527963PMID 37380728PMID 27964837PMID 19429873other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mohammad Shafi KuchayDivision of Endocrinology and Diabetes, Medanta The Medicity Hospital, Gurugram, 122001, Haryana, India. Electronic address: drshafikuchay@gmail.com.
Sunil Kumar MishraDivision of Endocrinology and Diabetes, Medanta The Medicity Hospital, Gurugram, 122001, Haryana, India.
Yatin MehtaInstitute of Critical Care, Medanta The Medicity Hospital, Gurugram, 122001, Haryana, India.
Medanta The Medicity · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Benzhydryl CompoundsCardiovascular DiseasesCoronary Artery BypassDiabetes Mellitus, Type 2Diabetic KetoacidosisFemaleGlucosidesHumansMiddle AgedPrognosisSodium-Glucose Transporter 2 InhibitorsBenzhydryl CompoundsempagliflozinGlucosidesSodium-Glucose Transporter 2 InhibitorsEmpagliflozinEuglycemic diabeti ketoacidosisSodium glucose cotransporter-2 inhibitors

Identifiers

PMID33915345
OpenAlexW3159829970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.